MONICA XIE: Open Payments
NPI 1053872226 · RANCHO CUCAMONGA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,462 in 56 payments from 16 companies in 2025. Trend: 2023 $370 · 2024 $842 · 2025 $1,462
Food & beverage: $1,462
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 9 | $248 |
| GlaxoSmithKline, LLC. | 8 | $227 |
| Verona Pharma, Inc. | 7 | $218 |
| Novo Nordisk Inc | 6 | $213 |
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $177 |
| Kowa Pharmaceuticals America, Inc. | 6 | $125 |
| Exact Sciences Corporation | 2 | $51 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $35 |
| Corcept Therapeutics | 1 | $28 |
| Sumitomo Pharma America, Inc. | 1 | $23 |
Products named: COSENTYX, Ohtuvayre, Kerendia, Ozempic, ZORYVE, AREXVY, SHINGRIX, Cologuard Collection Kit.
Industry payments across CA — which companies pay providers there.
